U2Bio Co., Ltd. (KOSDAQ:221800)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,140.00
-350.00 (-6.38%)
At close: Dec 5, 2025

U2Bio Revenue

U2Bio had revenue of 6.87B KRW in the quarter ending September 30, 2025, with 6.81% growth. This brings the company's revenue in the last twelve months to 25.59B, down -2.62% year-over-year. In the year 2024, U2Bio had annual revenue of 25.04B, down -18.68%.

Revenue (ttm)
25.59B
Revenue Growth
-2.62%
P/S Ratio
2.72
Revenue / Employee
n/a
Employees
n/a
Market Cap
69.62B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202425.04B-5.75B-18.68%
Dec 31, 202330.79B-38.22B-55.38%
Dec 31, 202269.01B58.01B527.29%
Dec 31, 201411.00B1.59B16.90%
Dec 31, 20139.41B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition